Many individuals diagnosed with CLL and SLL face a variety of stressors after being diagnosed, one of which is often the financial strain.

Chimeric Antigen Receptor T-cell (CAR-T) therapy is a potent cellular immune treatment that genetically trains an individual’s immune system (specifically, the T-cells, a type of white blood cell) to both recognize and attack cancerous cells.

Regular blood testing for those with CLL and SLL is an important part of managing the disease, as it can provide valuable insights into your overall health.

Most people who have been diagnosed with CLL or SLL have no symptoms initially and are usually advised that no treatment is necessary upon diagnosis

Integrative medicine is a patient-centered, evidence-informed field of comprehensive cancer care that uses mind-body practices, natural products, and lifestyle modifications from different traditions alongside conventional cancer treatments.

People with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) are at higher risk of developing infections due to having weakened immune systems.

MBL is a condition where there is an accumulation of abnormal B-cells in the blood. B-cells, also known as B-lymphocytes, are a type of white blood cell that makes antibodies to fight infections.

Measurable residual disease (MRD) testing measures the amount of cancer cells that are present in blood or bone marrow at the time the sample was collected.

Most people with chronic lymphocytic leukemia (CLL) at the time of diagnosis have no obvious symptoms and are often diagnosed based on the results of a routine blood test.